Summary report and presentations from EMA workshop on implementation of new pharmacovigilance legislation now available
On the 17th of June, the European Medicines Agency hosted a second workshop on the changes to the safety-monitoring of medicines in Europe, where it heard the expectations from patients, consumer groups, healthcare professionals and the pharmaceutical industry. The stakeholder forum involved discussions between the Agency, key stakeholder groups and medicines regulatory authorities from the European Union (EU) Member States.
For a list of the topics, and the preliminary slides click here.
Read more on the EMA website.